Long-Term Results of Wegovy: ​​Latest Findings from the SELECT Trial!

Video will be live on Monday, July 8 at 1:00 PM Central Time. 

▪️ Join my channel to get access to perks! 
▪️ Download my FREE 7-Day Best Weight Journal here.  
▪️ Subscribe to my YouTube channel here.   

–

A recent study published in May 2024 unveiled a long-term outcome of Semaglutide, known as Wegovy or Ozempic. This builds on the SELECT trial, which showed Wegovy could reduce major cardiovascular events by 20% in individuals with obesity and no diabetes. Conducted by Ryan et al., the study followed participants for 208 weeks, or about four years.

The primary finding was not a new side effect but a continuation of Wegovy’s benefits. Participants experienced an average weight loss of about 10%, maintained over the entire four-year period. Initially, participants lost weight until around week 65, then sustained this weight reduction for the remainder of the study.

The results are impressive. The weight loss was not just temporary but sustained throughout the study’s duration. This stability contrasts with other long-term studies, such as those with Saxenda, where there is a tendency for weight regain over time. Wegovy’s ability to maintain weight loss over four years underscores its potential as a long-term weight management solution.

Regarding actual side effects, the study found no new or alarming issues. There were no new cases of cancers or other unusual conditions. About 17% of participants stopped taking Wegovy due to gastrointestinal side effects, aligning with other studies of GLP-1 medications. This finding supports the overall safety and effectiveness of Wegovy for long-term use.

In summary, this research highlights that the long-term “side effect” of Wegovy is a continued benefit: sustained weight loss over four years. This study reinforces the drug’s role in effective and durable weight management.

Thanks for watching and always remember: small tweaks lead to massive peaks! 

References: Ryan, D.H., Lingvay, I., Deanfield, J. et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nat Med (2024). https://doi.org/10.1038/s41591-024-02996-7

–

Don’t forget to hit the subscribe button for more insightful content, and consider joining our YouTube Members Membership for exclusive benefits and monthly live sessions. 

–

Watch my previous videos to learn how to fight obesity and about the best medicine for weight loss: 
▪️ Watch This Before Taking Mounjaro  
▪️ From Ozempic to Mounjaro 
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro 
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!  
▪️ Ozempic: Stomach Paralysis Update  
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro  
▪️ Ozempic Paralyzed My Stomach 
▪️ How to Inject Mounjaro: step-by-step tutorial

–

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

–

Products I recommend to support your weight-loss journey: 
▪️ Managing Constipation 
▪️ Managing Diarrhea 
▪️ Managing Heartburn 
▪️ Internalized Weight Bias 
▪️ Protein Bars
▪️ Scales and More 
▪️ Supplements 
▪️ Activity Trackers  
▪️ My favorite Books 

– 

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link –
https://healthevolved.co/long-term-wegovy

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

What Medications Should You NOT Take with Ozempic or Zepbound?

If you’re taking Ozempic, Wegovy, Mounjaro, or Zepbound alongside other medications or supplements, I explain what to discuss with your pharmacist to help you feel prepared and confident. No shame, no overwhelm — just clear, practical guidance for real life on treatment.

CagriSema vs Mounjaro: Which Weight Loss Drug Won?

I compare CagriSema vs Mounjaro (tirzepatide) head-to-head in the REIMAGINE 4 and REIMAGINE 5 trials for weight loss and A1C lowering in type 2 diabetes and obesity. I explain why dose, trial design, and your personal blood sugar and weight goals matter more than headlines claiming one clear winner.

Retatrutide Isn’t Working the Same for Everyone

People with type 2 diabetes lost about 19% of body weight on retatrutide in TRIUMPH-2, compared to about 25% in people without diabetes. I explain the biology behind that gap and what meaningful progress looks like beyond the scale.

Burning, Crawling, Buzzing Skin on GLP-1s

Burning, crawling, or sunburnt-feeling skin is one of the least discussed Ozempic side effects, and the trial data shows it climbing steeply with each dose. I walk through the dose-by-dose semaglutide side effect numbers, the three leading theories on why a gut hormone would make your skin hurt, and the simple steps that settle it without costing you your progress.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.